Breast Cancer Biomarker- OptraSCAN Inc
OptraSCAN Inc offers breast cancer biomarker analysis for analysis of breast carcinoma. Breast cancer is the most common forms of cancer among woman. It can cause unfavorable effect if left neglected for a long time. Its early examination provides vital treatment. Advanced techniques of image analysis have potential to reduce the workload in a typical clinical lab.
Breast Carcinoma Analysis technology aims at analyzing and interpreting breast
carcinoma images thus it identifies quality of tumor. It also highlights and measures areas
of invasive carcinoma and DCIS (Ductal Carcinoma in Situ). Parameters that can
be identified includes the total tissue area, tumor area as well as invasive
cellularity. This acts
diagnostic tool to provide the pathologist in making the above identifications,
which otherwise could be greatly challenging and time-consuming.
Features:
·
Evaluation
of tumor (invasive carcinoma) area and the tissue area
·
Automated
evaluation of invasive cellularity in the tumor area
·
Identification
of DCIS
Contact us
at- info@optrascan.com
Read more
about- Breast Cancer Biomarker Analysis
Comments
Post a Comment